|
| Contact Information |
Cmdbioscience
Mark Jarosinski
Voice:317-313-9713
|
| Visit Our Site |
|
|
|
|
|
|
25 Press Releases | Medical |
CMD BIOSCIENCE ANNOUNCED TODAY IT IS PRESENTING AT THE ROCHE COLORADO CORPORATION PEPTIDE SYMPOSIUM 2011 IN BOULDER COLORADO. |
CMD BIOSCIENCE ANNOUNCED TODAY IT IS PRESENTING AT THE ROCHE COLORADO CORPORATION PEPTIDE SYMPOSIUM 2011 IN BOULDER COLORADO. |
|
|
|
|
|
New Haven, CT September 8th , 2011: CMDBioscience announced today that they will present at the Roche Colorado Corporation Peptide Symposium 2011 in Boulder Colorado. The company will present recent case studies related to CMDInventusSM, their proprietary computational discovery platform aimed at discovering novel peptide candidates in the Peptide Technology Showcase. |
|
|
|
|
|
|
|
|
|
\25 Press Releases\
September 08, 2011 - FOR IMMEDIATE RELEASE
CMD BIOSCIENCE ANNOUNCED TODAY IT IS PRESENTING AT THE ROCHE COLORADO CORPORATION PEPTIDE SYMPOSIUM 2011 IN BOULDER COLORADO.
New Haven, CT September 8th , 2011: CMDBioscience announced today that they will present at the Roche Colorado Corporation Peptide Symposium 2011 in Boulder Colorado. The company will present recent case studies related to CMDInventusSM, their proprietary computational discovery platform aimed at discovering novel peptide candidates in the Peptide Technology Showcase.
CMDInventusSM offers pharmaceutical, biotech and life science companies a ground breaking tool to assist with their peptide discovery projects. CMDInventusSM has been fully validated by multiple research projects, including a project aimed at identifying novel dengue virus anti-infective agents. CMDBioscience scientists used CMDInventusSM to interrogate a key dengue viral protein structural motif and rationally design small peptides that bound to the motif. The project, completed in seven weeks time, involved the explicit con...
|
|
